Malik Peiris to Pandemics
This is a "connection" page, showing publications Malik Peiris has written about Pandemics.
Connection Strength
0.192
-
What can we expect from first-generation COVID-19 vaccines? Lancet. 2020 11 07; 396(10261):1467-1469.
Score: 0.030
-
Infection of dogs with SARS-CoV-2. Nature. 2020 10; 586(7831):776-778.
Score: 0.029
-
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020 04; 25(16).
Score: 0.029
-
Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment. J Infect Dis. 2018 08 24; 218(7):1054-1060.
Score: 0.026
-
Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun. 2021 01 04; 12(1):63.
Score: 0.008
-
Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020 10 23; 371:m3862.
Score: 0.008
-
Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020. Emerg Infect Dis. 2020 12; 26(12):3076-3078.
Score: 0.008
-
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease. Emerg Infect Dis. 2020 11; 26(11):2701-2704.
Score: 0.007
-
Antibody Profiles in Mild and Severe Cases of COVID-19. Clin Chem. 2020 08 01; 66(8):1102-1104.
Score: 0.007
-
SARS-CoV-2 infection in conjunctival tissue - Authors' reply. Lancet Respir Med. 2020 07; 8(7):e58.
Score: 0.007
-
Emergence of a novel human coronavirus threatening human health. Nat Med. 2020 03; 26(3):317-319.
Score: 0.007
-
Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice. Eur J Immunol. 2021 09; 51(9):2296-2305.
Score: 0.002
-
Nowcasting epidemics of novel pathogens: lessons from COVID-19. Nat Med. 2021 03; 27(3):388-395.
Score: 0.002
-
In-Flight Transmission of SARS-CoV-2. Emerg Infect Dis. 2020 11; 26(11):2713-2716.
Score: 0.002
-
SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China. Emerg Infect Dis. 2020 12; 26(12):3071-3074.
Score: 0.002
-
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020 10; 21(10):1293-1301.
Score: 0.002
-
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020 09 04; 369(6508):1210-1220.
Score: 0.002
-
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.
Score: 0.002
-
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020 07; 583(7818):834-838.
Score: 0.002
-
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020 07; 8(7):687-695.
Score: 0.002
-
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 2020 06; 178:104786.
Score: 0.002
-
Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020 05; 26(5):676-680.
Score: 0.002
-
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. 2020 04 01; 66(4):549-555.
Score: 0.002
-
Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020 06; 20(6):656-657.
Score: 0.002